United States
US 12,697,385 B2
Combination therapy for cancer with anti-B7-H4 antibodies and anti-PD-1 antibodies
US 12,697,385 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Five Prime Therapeutics, Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Five Prime Therapeutics, Inc.
- Inventors
- Sandeep P. INAMDAR; Helen L. COLLINS; Hong XIANG; Xiang ZHANG; Neyssa MARINA
- Publication date
- 2026-08-04
- Filing date
- 2021-04-07
- Document type
- B2 Granted patent
- Also written as
- US 12,697,385 B2 · US12697385 · 12697385
Abstract
The present disclosure provides methods of administering antibodies and antigen-binding fragments thereof that specifically bind to human B7-H4 to a subject in need thereof, for example, a cancer patient, in combination with a PD-1/PD-L1 antagonist, such as an anti-PD-1 antibody.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free